Private Payer 101 Panelist Discussion

Chris Pryce invited to speak to Department Heads of a Multinational Pharmaceutical company specializing in Specialty biologics on the state of the Employee Benefits Industry and the Private Payer marketplace.

What do you think?
Insights

More Related Articles

The here and now of pharmacogenetic testing

2025 Canadian Leadership Council on Drug Plan Partnerships

e2r Blog Post Alerts – Sick Notes